Inhalational anesthetic induction

Inhalational anesthetic induction

Inhalational induction is common in pediatric patients, and the potent inhaled anesthetic agents are excellent bronchodilators. The only exception is desflurane, which has mild bronchoconstriction activity.
The potent inhaled agents decrease skeletal muscle tone in a dose-dependent fashion, which often improves surgical exposure.

Mode Of Action

Acts on GABA-A, glycine, and glutamate receptors.

Disadvantage

  • Inhalational induction time is longer; therefore, this technique is not suitable for rapid sequence intubation (RSI). 
  • Higher incidence of postoperative nausea and vomiting. 
  • All potent volatile anesthetic agents cause dose-dependent systemic vasodilation and may decrease blood pressure.
  • All potent inhaled agents cause dose-dependent respiratory depression.

Inhalational anesthetic drugs

Inhalational anesthetic induction

Comments

Claudio Elias Do Nascimento 348.438.21 visualizações said…
Tem uns pastor que coloca a mão na testa da pessoa e assopra no rosto e a pessoa dorme na hora,já outros manda todos fazer fila ai diz que o palito é ungido ai passa o palito no rosto do povo cai a fila toda no chão temos que vigiar com esses cai cai na unção movimento cai cai repouso no espirito,eu estava vendo no youtube o colete ungido do paator F e l ¡ c ¡ a n o depois estudei inalador de T u f f ¡ e r
December 4, 2016 at 10:23 AM
Unknown said…
This comment has been removed by a blog administrator.
April 18, 2017 at 9:44 AM
Post a Comment

Popular posts from this blog

Pharmacy Examining Board of Canada Questions & Answers

Image
Overview Q1 What is the Pharmacy Examining Board of Canada? The Pharmacy Examining Board of Canada ( PEBC ) is the national certification body for the pharmacy profession in Canada. PEBC is a non-profit organization with more than 40 years of experience in assessing the qualifications and competence of candidates for licensing by pharmacy provincial regulatory authorities. Established by Special Act of Parliament on December 21,1963, PEBC functions as an arms-length national examining board for pharmacists seeking entry-to-practice licensure in Canada. Q2 What is the purpose of the PEBC?
Read more

Paints in pharmacy| glycerin borax preparation is the first

Image
(1) GLYCERIN BORAX PREPARATION 13% Borax 13gm Glycerin to 100ml Levigate the borax powder into a suitable amount of glycerin then complete to 100ml.  Glycerin of borax uses: Used as a soothing agent in mouth ulcers also used in nipple fissures. (2) GLYCERIN TANNIC ACID PAINT 15% Tannic acid 15gm Glycerin to 100 ml Astringent in spongy gum and sore throat and applied to eyelid in trachoma. 1g of Na-citrate can be added (3) Glycerin borax and Tr.benzoin SOLUTION Glycerin borax 20 ml Tr.benzoin 10 ml Used in nipple fissure (4) DENTAL GLYCERIN ( zinc chloride) ZnCL2 1gm Glycerin 1.6ml H2O 0.5ml Alcohol 1.5ml used for de-sensation for exposed dentin (5) GENTIAN VIOLET PAINT (Rosaniline dyes) Gentian violet 1 gm Alcohol 70% 100 ml Used as antiseptic and in moniliasis. 2g of G. V can be used with 100 ml of glycerin borax in breast fissures. (6) ALCOHOLIC MERCUROCHROME PAINT Mercurochrome 2gm Alcohol 70% to 100 ml (7) Mercurochrom...
Read more

Facts about SOVALDI Therapy

Image
SOVALDI  It is a nucleotide analog polymerase inhibitor, that use in patients with chronic hepatitis C, in combination with ribavirin or interferon plus ribavirin, and the cure rate in clinical trials reached 95%. Here is some facts about SOVALDI that pharmacist must know: Active constituent of SOVALDI is sofosbuvir 400 mg. SOVALDI is effective against the four genotypes of HIV infection, including patients with HCC that in waiting list for liver transplantation, and those carrying HIV-1/HCV co-infection. SOVALDI not recommended using alone for Chronic Hepatitis C patients. The dose of SOVALDI is 400 mg once daily, to be taken regardless of food. Genotype-1 HCV treated for 12 weeks with SOVALDI +Peginterferon alfa +ribavirin, and for 24 weeks if used without peginterferon alfa. Genotype-2 HCV treated for 12 weeks with SOVALDI +ribavirin. Genotype-3 HCV treated for 24 weeks with SOVALDI +ribavirin. Genotype-4 treated for 12 weeks with SOVALDI +Peginterferon a...
Read more